These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25438650)

  • 1. [Advanced glycation end products: A risk factor for human health].
    Wautier MP; Tessier FJ; Wautier JL
    Ann Pharm Fr; 2014 Nov; 72(6):400-8. PubMed ID: 25438650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of dietary advanced glycation end products in rats.
    Poulsen MW; Andersen JM; Hedegaard RV; Madsen AN; Krath BN; Monošík R; Bak MJ; Nielsen J; Holst B; Skibsted LH; Larsen LH; Dragsted LO
    Br J Nutr; 2016 Feb; 115(4):629-36. PubMed ID: 26824730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Maillard reaction in the human body. The main discoveries and factors that affect glycation.
    Tessier FJ
    Pathol Biol (Paris); 2010 Jun; 58(3):214-9. PubMed ID: 19896783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, advanced glycation endproducts and vascular disease.
    Wautier JL; Guillausseau PJ
    Vasc Med; 1998; 3(2):131-7. PubMed ID: 9796076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts.
    Osawa M; Yamamoto Y; Munesue S; Murakami N; Sakurai S; Watanabe T; Yonekura H; Uchigata Y; Iwamoto Y; Yamamoto H
    Biochim Biophys Acta; 2007 Oct; 1770(10):1468-74. PubMed ID: 17714874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model.
    Pageon H
    Pathol Biol (Paris); 2010 Jun; 58(3):226-31. PubMed ID: 19896301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
    Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
    J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
    Yamagishi S
    Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycation, glycoxidation and diabetes mellitus].
    Boulanger E; Wautier JL; Dequiedt P; Schmidt AM
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S8-16. PubMed ID: 17378134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aging: role and control of glycation].
    Boulanger E; Puisieux F; Gaxatte C; Wautier JL
    Rev Med Interne; 2007 Dec; 28(12):832-40. PubMed ID: 17597260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
    Okamoto T; Yamagishi S; Inagaki Y; Amano S; Koga K; Abe R; Takeuchi M; Ohno S; Yoshimura A; Makita Z
    FASEB J; 2002 Dec; 16(14):1928-30. PubMed ID: 12368225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal tails of 4,4'-diphenylmethane-bis(methyl) carbamate are essential for binding to receptor for advanced glycation end products to attenuate advanced glycation end products-induced inflammation and apoptosis responses in human umbilical vein endothelial cells.
    Feng L; Zhu MM; Bu WQ; Wang CF; Zheng ZG; Wang RS; Jia XB; Zhu Q
    J Pharm Pharmacol; 2016 Jan; 68(1):93-106. PubMed ID: 26806697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
    Wautier JL; Zoukourian C; Chappey O; Wautier MP; Guillausseau PJ; Cao R; Hori O; Stern D; Schmidt AM
    J Clin Invest; 1996 Jan; 97(1):238-43. PubMed ID: 8550841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells.
    Zhou J; Cai B; Jang YP; Pachydaki S; Schmidt AM; Sparrow JR
    Exp Eye Res; 2005 Apr; 80(4):567-80. PubMed ID: 15781285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.